About three years ago, Eddie Floyd, owner of a pet center in Austin, Texas, felt a severe pain in his chest and rushed to a hospital to find that he had had a heart attack. Afterwards, doctors asked him to participate in a trial that involved adult stem cells being injected into his heart.  He got lucky and qualified!
 
"They (the stem cells) did not cause any kind of rejection, so I didn't have to have any rejection-preventive medicine or anything like that," he explained  "They were just generic stem cells that became heart."

Doctors say that within days after a heart attack, damaged cells are sending a signal for help. Millions of stem cells injected into the system respond to those signals, "and it has apparently regenerated the muscle that died during my heart attack," Floyd notes.

He further reports that he has been able to resume normal activity.  "There really isn't anything that I can't do because of my heart, that I'm aware of. [But] there are a few things I can't do because of my belly...," the pet store owner joked.


In this study, adult stem cells are harvested from adults between the ages of 18 and 30 and are processed to remove elements that cause rejection. 


Adult stem cells are successfully treating more than 70 diseases and conditions, while embryonic stem-cell research has produced zero results. Proof?  There have been over 1300 ASC clinical trials registered (from around the world) by the USA National Institutes of Health.  The USA itself has over 50 on heart disease alone. 
Embryonics?  As I never get tired of saying. ZERO—NADA---ZILCH—RIEN---NICHTS---NICHEVO.  It is a hoax that never will go to trial in your lifetime because just one cancer death would kill the embryonic hoax forever. 

All you have to do is meet Kyle Loh to realize he's a pretty normal kid, except he is on a mission.
"I like dance music a lot," this 16-year-old said as he listened to Lady Gaga on his MacBook Pro.

But elsewhere on his computer is his most recent paper entitled "Chemical Inhibitors of TGF-beta Signaling and Other Molecules Replace Sox-2 in the Pluripotent Reprogramming of Differentiated Human and Marine Cells."
Or, as he explained it in English: "How skin cells can turn into stem cells."

So, yes, Kyle is very smart.
He had to be to to have gone straight from Eighth grade (when he was 13) in Mendham to college (okay, he cheated a little; he spent part of his last year in middle school at the County College of Morris), and then to graduate from Rutgers University in only two and a half years.

Should we mention that while he was 14 and 15, he spent a total of two summers and one semester studying and researching at Harvard's Stem Cell Institute?

His passion is the promise of healing that stem cells can bring to people with various diseases or spinal injuries -- a field he was able to pursue at the UMDNJ Robert Wood Johnson Medical School which partners with Rutgers.

Kyle's emphasis right now, in light of the ethical debate over using embryonic stem cells for research, is to find a way to turn skin cells into usable stem cells.  See above: "Chemical Inhibitors of TGF-beta... " well, you get the idea.  But he says he mixes well with all ages, and doesn't feel socially isolated.  For example, he likes "The Office" on TV.   But when he was asked if he has ever seen Snooki on the "Jersey Shore" program that's all the rage with many young adults, he responded "I think that's way before my time."
We took that as a 'No.'

"He's mature for his age," said his Mom, Doreen Loh, 50, a senior data analyst at the Cancer Institute of New Jersey.  And while she was concerned about him missing the social life of high school, she said he reassured her by saying,  "I'm sorry Mom, I cannot be a cookie cutter son."

What's next for this 16 year old whiz kid?
For starters, he does have a driver's permit.
But this summer he will be studying and researching at the Genome Institute of Singapore, so it seems unlikely he'll get much driving experience there.

This fall, he will pursue his Ph.D. at Stanford and within four years or so hopes to land a research position.
By then he should be 20, or 21 at the outside.

From nbcnewyork.com

I am not Catholic.  I am dead-neutral on the embryonic debate.  I believe the embryonic “moral” issue was trumped up by Big Medicine to keep our eyes on the hopeless debate instead of on the fact that embryonic stem cells cannot ever work.   Their goal is to use any means possible to keep Repair Stem Cells, the only stem cells that have ever worked and ever will work, from reducing their profits. 

The medical system most of the developed world is forced to live with:

1. Profits are the only thing that matters
2. No cures of any chronic disease are allowed, since cures kill profits.
3. Patients are lab rats, created to buy test drugs which are now approved on fictional data from fictional clinical trials.

So it is with gratitude I commend the Vatican for last week’s announcement that the church is not only supporting the stem cells that work, but is financing research.  Nothing says it better than this piece by Flavia Colgan in the Huffington Post:

The Pope and the art of Jeremy Kenyon Lockyer Corbell  (Extract from The Huffington Post)

I have written about mixed-media artist Jeremy Kenyon Lockyer Corbell recently and am doing so again as he is consistently ahead of his time. As a pioneer in the world of art, Corbell is constantly attacking issues that are both personal and political no matter how big or small.

I recently acquired a piece by Corbell on loan titled "The Pope" which shows Pope John Paul II donning a huge stem-cell halo. As we are aware, the Vatican has just contributed $3 million to fund a research initiative working to find a new way to develop multi-purpose stems cells -- without using embryonic cells. We are seeing a progressive and compassionate Church that is also ahead of their time.

We see a Church not only embracing technology and discovery, but advancing it. Together, art and religion are pushing the political and societal envelope. Church that is also ahead of their time. We see a Church not only embracing technology and discovery, but advancing it. Together, art and religion are pushing the political and societal envelope.

On April 18, 2010, CBS Sixty Minutes condemned to death millions of people with an outrageous program detailing one fraudulent “doctor” who used stem cells to cheat desperate patients.  They knew absolutely that their expose’ would paint a hundred  honest stem cell doctors with the same dirty brush.

Why did they search the world to find one juicy fraud and ignore hundreds of good, honest doctors?  Answer: They knew that would prevent the average American from complaining about being deprived of stem cells which work, stem cells which would reduce the profits of the billionaires who have turned the USA into a medical prison, where profits come first and patients come last.

Don Margolis knew the answer to this question in 2007, when he wrote:

The $100 Billion Scam
How the absurd stem cell debate in America is destroying human life by the hundreds everyday, while enriching the powerful, whose motto is: “We shall lie and you must die, but we shall profit greatly.”

Here is the preface to Don’s book, which names the names of the money-hungry scientists, universities, politicians, and doctors who lie about stem cells every day at the behest of the billionaires who control medicine and will never allow stem cells to reduce their profits of TWELVE MILLION DOLLARS PER HOUR.  Read this preface and you will understand why CBS Sixty Minutes had no choice but to pull off this propaganda coup.  It was easy---show one fraud and then glide over to the conclusion that ALL stem cell doctors are fraudulent.  Sixty Minutes’ bosses are proud---they kept stem cells away from America for decades with just one shameful hours.

Read More Here.

As we tell you every chance we get, virtually everything you hear about stem cells in America is a lie---especially the nonsense about the science fiction known as “embryonic stem cells.”  However, those USA researchers who are using the only stem cells that work, Adult Stem Cells, also exaggerate regularly about their “new” “groundbreaking” discoveries.

Bioheart is a Florida company, one which we have long admired for its efforts to bring stem cells to the thousands of heart patients who could live longer and better lives rather than suffer with the obsolete, toxic medicines their doctors are forced to use.

Notice in this article about a new clinical trial in Jordan, how CEO Karl Groth carefully explains, without exaggeration, the potential benefits of his truly groundbreaking product.  But then read this statement from the doctor in Jordan who is running the trial.  His statement wasn’t even true five years ago! 

“He said that until now heart muscle damage was considered irreversible and permanent.”

That is something we hear from USA promoters all the time. The super hype bologna is now in the middle-east!
VesCell (Thailand, Israel, Dominican Rep) has treated 500 patients, starting 1/1/05, with autologous stem cells, while the Johann Strauss Institute in Frankfurt has done about that many---all OUTSIDE clinical trials, for patients who once had no options and no hope.   90%+ of VesCell’s patients would not qualify for any trial.  Indeed, over half of them could not even qualify for a transplant!

So, Dr. Imad, we are sorry you are five years behind the times, as most Americans are.  We wish you the best in your upcoming trial.

For the complete article:
http://www.ameinfo.com/228968.html
 

Right now there are millions of individuals whose lives are directly dependent on the rate at which new drugs come to market. I'm one of them. I'm fighting for my life.

To date, half of my intestine has been removed to manage Crohn's disease. Last year, at age 23, I enrolled in a clinical trial for a treatment that could save my life: an adult stem-cell therapy that helps damaged intestinal tissue regenerate from the relentless inflammation and scarring caused by Crohn's.

The sponsor, Osiris Therapeutics, reported that Crohn's patients in the therapy's Phase II trial all experienced clinical improvement after receiving the cells. A Phase III trial for the treatment is now nearing completion, but Food and Drug Administration (FDA) approval could be years away, despite its FDA "fast track" designation.

In accordance with antiquated FDA policies, the Phase III trial is randomized with three groups of patients, and double-blinded, which means neither the doctors nor patients are told what treatment is being administered. One group received full-strength stem cells, another received half-strength, and a third got a placebo (the proverbial "sugar pill"). It appears I got the placebo.

Foregoing all other treatments, I received the four scheduled infusions, and yet my disease progressed with a vengeance. In a matter of weeks, I became dangerously malnourished. I've since been readmitted to the hospital countless times, as my doctors continue to plead with Osiris for information. But Osiris has refused, citing adherence to FDA protocol.

I am now a lab rat. I have no right to know what happened to me in the study, nor do I have a right to try the promising treatment as my health deteriorates. It doesn't have to be this way.

To which I RESPOND:

Sorry, young man, we are all lab rats for the billionaires who profit from this “pills only” medical system.  There isn’t a clinical trial for any drug approved THIS CENTURY that is honest.  They just make up the data, get approval from the FDA, which they own, and wait for the deaths of us lab rats to decide whether or not stopping the deaths is worth losing their profits.  At one time 25 or so years ago, big corporations worried about lawsuits, but since they now control what used to be a legal system, lawsuits are not a problem—they own that system too. 

Don’t believe it?  Five years after the Vioxx criminally fraudulent clinical trials killed over 50,000, guess how many widows actually got a lawsuit filed?  Sorry, wrong number.  It was 18.  Simple.  Just change the rules with a congress you own and all the giants have to do is delay, delay, delay.  Of course the fully controlled Supreme Court hasn’t ruled against a big corporation THIS CENTURY.

So, dear Vioxx widow, your choice is simple—settle for the $10,000 we value your late husband’s life at, or your grandchildren will accept the $5000 we offer them in 2034.

 

CALI SAYS NO TO EMBRYONIC, YES TO ADULT...SO SHOULD NY

Release date: 4/3/2010

California has shifted from embryonic to adult stem cell research...New York State should follow.

Published: Saturday, April 03, 2010

SANDI's TRIUMPH OVER Multiple Sclerosis + Hearing Disorders (Tinnitus)

Weekly update - March 26, 2010

For a refresher on Sandi's condition and where it all started:

Windpipe transplant success in UK child

This is the third such transplant to be done, and the first in a child A 10-year-old British boy has become the first child to undergo a windpipe transplant with an organ crafted from his own stem cells. It is hoped that using the boy's own tissue in the nine-hour operation at Great Ormond Street Hospital will cut the risk of rejection. The world's first tissue-engineered windpipe transplant was done in Spain in 2008 but with a shorter graft. Doctors say the boy is doing well and breathing normally.   He has a rare condition called Long Segment Congenital Tracheal Stenosis, in which patients are born with an extremely narrow airway. At birth his airway was just one millimetre across. Doctors had previously operated to expand his airway but in November last year he suffered complications from erosion of a metal stent in his windpipe or trachea. In order to build him a new airway, doctors took a donor trachea, stripped it down to the collagen scaffolding, and then injected stem cells taken from his bone marrow.The organ was then implanted in the boy and over the next month, doctors expect the stem cells to transform into specialised cells which form the inside and outside of the trachea.   Pioneering Two years ago, Claudia Castillo, a 30-year-old mother of two, became the first person to receive a transplant organ created from stem cells.  She received a new section of trachea after her own had been damaged by tuberculosis. The latest operation is a significant advance on that pioneering work, as it is the first time a whole tissue engineered windpipe has been transplanted. PERSONAL VIEWPOINT Carley Bowman, mother of a son with the same condition "I cannot tell you what hope this gives us as a family.  My three-year-old son has Long Segment Congenital Tracheal Stenosis. He had surgery to widen his windpipe a year ago.   Our son has had a relatively straight-forward recovery, but we live with the constant fear that his condition may deteriorate. Should he suffer complications in the future, there are a range of procedures already at his surgeon's disposal. These are designed to improve quality of life. But should the worst happen and our son's condition become life-threatening once again, knowing there is now the possibility of a tracheal transplant is a very liberating feeling."   Also in Ms Castillo's case, doctors grew the new tissue from her stem cells in the laboratory.  But in the UK operation, the donor windpipe was treated with a cocktail of chemicals designed to prompt the stem cells to grow into new tissue once inside the body.   Professor Martin Birchall, head of translational regenerative medicine at University College London, who was part of the team behind the operation, said it was a "real milestone".  "It is the first time a child has received stem cell organ treatment, and it's the longest airway that has ever been replaced.  "I think the technique will allow not just highly specialised hospitals to carry out stem cell organ transplants."   He said more clinical trials were needed to prove the technique worked but that the team was also thinking about transplanting other organs, such as the oesophagus.  Professor Anthony Hollander, ARC professor of rheumatology and tissue engineering at the University of Bristol, said: "The advantage of the new approach is that it can be performed quickly and cheaply and so if successful it could be made available to large numbers of patients at relatively low cost."   But he said the technique was more unpredictable than that done in the laboratory because there is less control of the type of stem cells being used and a very short time between seeding the cells onto the scaffold and implantation.  Stem cell pioneer Professor Paolo Macchiarini, from Careggi University Hospital in Florence was involved in both the Spanish and UK transplants.   He had also carried out the stem cell procedure on a 53-year-old Italian woman.